CHRISTOPHER CERIALE: Open Payments
NPI 1255858221 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 24 payments from 13 companies in 2025. Trend: 2023 $353 · 2024 $227 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $95 |
| Endo USA, Inc. | 4 | $89 |
| Boston Scientific Corporation | 2 | $67 |
| ConvaTec Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $54 |
| COLOPLAST CORP | 2 | $43 |
| Verity Pharmaceuticals Inc. | 2 | $36 |
| PFIZER INC. | 1 | $27 |
| Integra LifeSciences Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: GEMTESA, XIAFLEX, CURE CATHETER, BOTOX, Axonics, Luja Coude, Tlando, XTANDI.
Industry payments across CA — which companies pay providers there.
